Delivery Order SPE2DX22D0049-SPE2D826FA1YS
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a $8,026.53 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 20, 2025, with an ultimate completion date of the same day. The contract, which received no set-aside designation, was competitively awarded and represents a child delivery order under AmerisourceBergen's larger prime indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $210,271.14 to AmerisourceBergen Drug Corp on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The delivery order will be performed at the vendor's Corporate...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $30,056.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on July 14, 2025, with an ultimate completion date of July 15, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026. The delivery order will...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $14,651.24 delivery order (Contract 4569447475) to AmerisourceBergen Drug Corp on September 15, 2025, with completion targeted for September 16, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $11,772.66 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 22, 2025, with completion scheduled for July 23, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion vehicle extending through December 2026. The delivery order will be performed at AmerisourceBergen's corporate office...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $12,826.05 firm fixed-price delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on November 12, 2025, with a completion date of November 13, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract is for pharmaceutical and medical supply...
- The Defense Logistics Agency's Medical Supply Chain awarded a $37,470.84 delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on November 24, 2025, with an ultimate completion date of November 25, 2025. This firm fixed price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion prime vehicle running through December 2026. The delivery order will be performed at the...
- The Defense Logistics Agency's Medical Supply Chain awarded a $19,105.32 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price contract, issued without set-aside restrictions, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The work will be performed at AmerisourceBergen's...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $572,991.51 to AmerisourceBergen Drug Corp on November 20, 2025, with an ultimate completion date of November 21, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement extending through December 2026. The delivery order will be...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $30,418.84 by the Defense Logistics Agency's Medical Supply Chain on November 23, 2025, with an ultimate completion date of November 24, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999.99 million through December 2026. The delivery order will be fulfilled from the vendor's...
- SPE2DX22D0049Indefinite Delivery Contract
- SPE2DX22D0049-SPE2D826FA1YSDelivery Order
The U.S. Defense Logistics Agency Medical Supply Chain awarded a $167,107.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 24, 2025, with an ultimate completion date of November 25, 2025. This non-set-aside contract (CAGE 0U9U0) represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime vendor agreement valued through December 2026. The delivery order will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen supplies comprehensive medical commodities to support military and federal healthcare systems, including brand-name and generic medications, vaccines, medical devices, and specialized pharmaceuticals across multiple therapeutic domains. This delivery order falls within the scope of AmerisourceBergen's existing pharmaceutical prime vendor relationship with DLA, which enables the company to fulfill medical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems on a global basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $167.1k | 11/23/25 |